0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Cinnarizine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-14R8292
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Cinnarizine Market Insights Forecast to 2028
BUY CHAPTERS

Cinnarizine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-14R8292
Report
November 2024
Pages:142
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cinnarizine - Market Size

The global market for Cinnarizine was estimated to be worth US$ 2527 million in 2023 and is forecast to a readjusted size of US$ 3596.1 million by 2030 with a CAGR of 5.2% during the forecast period 2024-2030

Cinnarizine - Market

Cinnarizine - Market

Cinnarizine is an antihistamine and calcium channel blocker of the diphenylmethylpiperazine group. It is also known to promote cerebral blood flow, and so is used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis. However, it is more commonly prescribed for nausea and vomiting due to motion sickness or other sources such as chemotherapy, vertigo, or Ménière's disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cinnarizine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cinnarizine by region & country, by Type, and by Application.
The Cinnarizine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cinnarizine.
Market Segmentation

Scope of Cinnarizine - Market Report

Report Metric Details
Report Name Cinnarizine - Market
Forecasted market size in 2030 US$ 3596.1 million
CAGR 5.2%
Forecasted years 2024 - 2030
Segment by Type:
  • Hospital
  • Drug Store
  • On-line
Segment by Application
  • Antiemetic Agent
  • Histamine H₁-Receptor Antagonist
  • Antivertigo Agent
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Goodwill Pharma, Zambon, Gedeon Richter, Johnson and Johnson, Hasco-Lek, Teva, Sopharma, Aurobindo Pharma, Novartis, Mylan, Eurogenerics, Nidda Healthcare, Apotex, Leti Pharma, Allena Pharmaceuticals, Inga Laboratories, March Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Cinnarizine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Cinnarizine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Cinnarizine in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Cinnarizine - Market size in 2030?

Ans: The Cinnarizine - Market size in 2030 will be US$ 3596.1 million.

Who are the main players in the Cinnarizine - Market report?

Ans: The main players in the Cinnarizine - Market are Goodwill Pharma, Zambon, Gedeon Richter, Johnson and Johnson, Hasco-Lek, Teva, Sopharma, Aurobindo Pharma, Novartis, Mylan, Eurogenerics, Nidda Healthcare, Apotex, Leti Pharma, Allena Pharmaceuticals, Inga Laboratories, March Pharma

What are the Application segmentation covered in the Cinnarizine - Market report?

Ans: The Applications covered in the Cinnarizine - Market report are Antiemetic Agent, Histamine H₁-Receptor Antagonist, Antivertigo Agent

What are the Type segmentation covered in the Cinnarizine - Market report?

Ans: The Types covered in the Cinnarizine - Market report are Hospital, Drug Store, On-line

1 Market Overview
1.1 Cinnarizine Product Introduction
1.2 Global Cinnarizine Market Size Forecast
1.2.1 Global Cinnarizine Sales Value (2019-2030)
1.2.2 Global Cinnarizine Sales Volume (2019-2030)
1.2.3 Global Cinnarizine Sales Price (2019-2030)
1.3 Cinnarizine Market Trends & Drivers
1.3.1 Cinnarizine Industry Trends
1.3.2 Cinnarizine Market Drivers & Opportunity
1.3.3 Cinnarizine Market Challenges
1.3.4 Cinnarizine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cinnarizine Players Revenue Ranking (2023)
2.2 Global Cinnarizine Revenue by Company (2019-2024)
2.3 Global Cinnarizine Players Sales Volume Ranking (2023)
2.4 Global Cinnarizine Sales Volume by Company Players (2019-2024)
2.5 Global Cinnarizine Average Price by Company (2019-2024)
2.6 Key Manufacturers Cinnarizine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Cinnarizine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Cinnarizine
2.9 Cinnarizine Market Competitive Analysis
2.9.1 Cinnarizine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Cinnarizine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cinnarizine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hospital
3.1.2 Drug Store
3.1.3 On-line
3.2 Global Cinnarizine Sales Value by Type
3.2.1 Global Cinnarizine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cinnarizine Sales Value, by Type (2019-2030)
3.2.3 Global Cinnarizine Sales Value, by Type (%) (2019-2030)
3.3 Global Cinnarizine Sales Volume by Type
3.3.1 Global Cinnarizine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Cinnarizine Sales Volume, by Type (2019-2030)
3.3.3 Global Cinnarizine Sales Volume, by Type (%) (2019-2030)
3.4 Global Cinnarizine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Antiemetic Agent
4.1.2 Histamine H₁-Receptor Antagonist
4.1.3 Antivertigo Agent
4.2 Global Cinnarizine Sales Value by Application
4.2.1 Global Cinnarizine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cinnarizine Sales Value, by Application (2019-2030)
4.2.3 Global Cinnarizine Sales Value, by Application (%) (2019-2030)
4.3 Global Cinnarizine Sales Volume by Application
4.3.1 Global Cinnarizine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Cinnarizine Sales Volume, by Application (2019-2030)
4.3.3 Global Cinnarizine Sales Volume, by Application (%) (2019-2030)
4.4 Global Cinnarizine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Cinnarizine Sales Value by Region
5.1.1 Global Cinnarizine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cinnarizine Sales Value by Region (2019-2024)
5.1.3 Global Cinnarizine Sales Value by Region (2025-2030)
5.1.4 Global Cinnarizine Sales Value by Region (%), (2019-2030)
5.2 Global Cinnarizine Sales Volume by Region
5.2.1 Global Cinnarizine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Cinnarizine Sales Volume by Region (2019-2024)
5.2.3 Global Cinnarizine Sales Volume by Region (2025-2030)
5.2.4 Global Cinnarizine Sales Volume by Region (%), (2019-2030)
5.3 Global Cinnarizine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Cinnarizine Sales Value, 2019-2030
5.4.2 North America Cinnarizine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Cinnarizine Sales Value, 2019-2030
5.5.2 Europe Cinnarizine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Cinnarizine Sales Value, 2019-2030
5.6.2 Asia Pacific Cinnarizine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Cinnarizine Sales Value, 2019-2030
5.7.2 South America Cinnarizine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Cinnarizine Sales Value, 2019-2030
5.8.2 Middle East & Africa Cinnarizine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cinnarizine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cinnarizine Sales Value
6.2.1 Key Countries/Regions Cinnarizine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Cinnarizine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Cinnarizine Sales Value, 2019-2030
6.3.2 United States Cinnarizine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cinnarizine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cinnarizine Sales Value, 2019-2030
6.4.2 Europe Cinnarizine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cinnarizine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cinnarizine Sales Value, 2019-2030
6.5.2 China Cinnarizine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cinnarizine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cinnarizine Sales Value, 2019-2030
6.6.2 Japan Cinnarizine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cinnarizine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cinnarizine Sales Value, 2019-2030
6.7.2 South Korea Cinnarizine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cinnarizine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cinnarizine Sales Value, 2019-2030
6.8.2 Southeast Asia Cinnarizine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cinnarizine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cinnarizine Sales Value, 2019-2030
6.9.2 India Cinnarizine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cinnarizine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Goodwill Pharma
7.1.1 Goodwill Pharma Company Information
7.1.2 Goodwill Pharma Introduction and Business Overview
7.1.3 Goodwill Pharma Cinnarizine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Goodwill Pharma Cinnarizine Product Offerings
7.1.5 Goodwill Pharma Recent Development
7.2 Zambon
7.2.1 Zambon Company Information
7.2.2 Zambon Introduction and Business Overview
7.2.3 Zambon Cinnarizine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Zambon Cinnarizine Product Offerings
7.2.5 Zambon Recent Development
7.3 Gedeon Richter
7.3.1 Gedeon Richter Company Information
7.3.2 Gedeon Richter Introduction and Business Overview
7.3.3 Gedeon Richter Cinnarizine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Gedeon Richter Cinnarizine Product Offerings
7.3.5 Gedeon Richter Recent Development
7.4 Johnson and Johnson
7.4.1 Johnson and Johnson Company Information
7.4.2 Johnson and Johnson Introduction and Business Overview
7.4.3 Johnson and Johnson Cinnarizine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Johnson and Johnson Cinnarizine Product Offerings
7.4.5 Johnson and Johnson Recent Development
7.5 Hasco-Lek
7.5.1 Hasco-Lek Company Information
7.5.2 Hasco-Lek Introduction and Business Overview
7.5.3 Hasco-Lek Cinnarizine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Hasco-Lek Cinnarizine Product Offerings
7.5.5 Hasco-Lek Recent Development
7.6 Teva
7.6.1 Teva Company Information
7.6.2 Teva Introduction and Business Overview
7.6.3 Teva Cinnarizine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Teva Cinnarizine Product Offerings
7.6.5 Teva Recent Development
7.7 Sopharma
7.7.1 Sopharma Company Information
7.7.2 Sopharma Introduction and Business Overview
7.7.3 Sopharma Cinnarizine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Sopharma Cinnarizine Product Offerings
7.7.5 Sopharma Recent Development
7.8 Aurobindo Pharma
7.8.1 Aurobindo Pharma Company Information
7.8.2 Aurobindo Pharma Introduction and Business Overview
7.8.3 Aurobindo Pharma Cinnarizine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Aurobindo Pharma Cinnarizine Product Offerings
7.8.5 Aurobindo Pharma Recent Development
7.9 Novartis
7.9.1 Novartis Company Information
7.9.2 Novartis Introduction and Business Overview
7.9.3 Novartis Cinnarizine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Novartis Cinnarizine Product Offerings
7.9.5 Novartis Recent Development
7.10 Mylan
7.10.1 Mylan Company Information
7.10.2 Mylan Introduction and Business Overview
7.10.3 Mylan Cinnarizine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Mylan Cinnarizine Product Offerings
7.10.5 Mylan Recent Development
7.11 Eurogenerics
7.11.1 Eurogenerics Company Information
7.11.2 Eurogenerics Introduction and Business Overview
7.11.3 Eurogenerics Cinnarizine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Eurogenerics Cinnarizine Product Offerings
7.11.5 Eurogenerics Recent Development
7.12 Nidda Healthcare
7.12.1 Nidda Healthcare Company Information
7.12.2 Nidda Healthcare Introduction and Business Overview
7.12.3 Nidda Healthcare Cinnarizine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Nidda Healthcare Cinnarizine Product Offerings
7.12.5 Nidda Healthcare Recent Development
7.13 Apotex
7.13.1 Apotex Company Information
7.13.2 Apotex Introduction and Business Overview
7.13.3 Apotex Cinnarizine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Apotex Cinnarizine Product Offerings
7.13.5 Apotex Recent Development
7.14 Leti Pharma
7.14.1 Leti Pharma Company Information
7.14.2 Leti Pharma Introduction and Business Overview
7.14.3 Leti Pharma Cinnarizine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Leti Pharma Cinnarizine Product Offerings
7.14.5 Leti Pharma Recent Development
7.15 Allena Pharmaceuticals
7.15.1 Allena Pharmaceuticals Company Information
7.15.2 Allena Pharmaceuticals Introduction and Business Overview
7.15.3 Allena Pharmaceuticals Cinnarizine Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Allena Pharmaceuticals Cinnarizine Product Offerings
7.15.5 Allena Pharmaceuticals Recent Development
7.16 Inga Laboratories
7.16.1 Inga Laboratories Company Information
7.16.2 Inga Laboratories Introduction and Business Overview
7.16.3 Inga Laboratories Cinnarizine Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Inga Laboratories Cinnarizine Product Offerings
7.16.5 Inga Laboratories Recent Development
7.17 March Pharma
7.17.1 March Pharma Company Information
7.17.2 March Pharma Introduction and Business Overview
7.17.3 March Pharma Cinnarizine Sales, Revenue and Gross Margin (2019-2024)
7.17.4 March Pharma Cinnarizine Product Offerings
7.17.5 March Pharma Recent Development
8 Industry Chain Analysis
8.1 Cinnarizine Industrial Chain
8.2 Cinnarizine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cinnarizine Sales Model
8.5.2 Sales Channel
8.5.3 Cinnarizine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Cinnarizine Market Trends
    Table 2. Cinnarizine Market Drivers & Opportunity
    Table 3. Cinnarizine Market Challenges
    Table 4. Cinnarizine Market Restraints
    Table 5. Global Cinnarizine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Cinnarizine Revenue Market Share by Company (2019-2024)
    Table 7. Global Cinnarizine Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Cinnarizine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Cinnarizine Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Cinnarizine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Cinnarizine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Cinnarizine
    Table 13. Global Cinnarizine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cinnarizine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Cinnarizine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Cinnarizine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Cinnarizine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Cinnarizine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Cinnarizine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Cinnarizine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Cinnarizine Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Cinnarizine Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Cinnarizine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Cinnarizine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Cinnarizine Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Cinnarizine Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Cinnarizine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Cinnarizine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Cinnarizine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Cinnarizine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Cinnarizine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Cinnarizine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Cinnarizine Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Cinnarizine Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Cinnarizine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Cinnarizine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Cinnarizine Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Cinnarizine Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Cinnarizine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Cinnarizine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Cinnarizine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Cinnarizine Sales Value by Region (2019-2024) & (%)
    Table 44. Global Cinnarizine Sales Value by Region (2025-2030) & (%)
    Table 45. Global Cinnarizine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Cinnarizine Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Cinnarizine Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Cinnarizine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Cinnarizine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Cinnarizine Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Cinnarizine Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Cinnarizine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Cinnarizine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Cinnarizine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Cinnarizine Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Cinnarizine Sales Volume, (2025-2030) & (K Units)
    Table 57. Goodwill Pharma Company Information
    Table 58. Goodwill Pharma Introduction and Business Overview
    Table 59. Goodwill Pharma Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Goodwill Pharma Cinnarizine Product Offerings
    Table 61. Goodwill Pharma Recent Development
    Table 62. Zambon Company Information
    Table 63. Zambon Introduction and Business Overview
    Table 64. Zambon Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Zambon Cinnarizine Product Offerings
    Table 66. Zambon Recent Development
    Table 67. Gedeon Richter Company Information
    Table 68. Gedeon Richter Introduction and Business Overview
    Table 69. Gedeon Richter Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Gedeon Richter Cinnarizine Product Offerings
    Table 71. Gedeon Richter Recent Development
    Table 72. Johnson and Johnson Company Information
    Table 73. Johnson and Johnson Introduction and Business Overview
    Table 74. Johnson and Johnson Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Johnson and Johnson Cinnarizine Product Offerings
    Table 76. Johnson and Johnson Recent Development
    Table 77. Hasco-Lek Company Information
    Table 78. Hasco-Lek Introduction and Business Overview
    Table 79. Hasco-Lek Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Hasco-Lek Cinnarizine Product Offerings
    Table 81. Hasco-Lek Recent Development
    Table 82. Teva Company Information
    Table 83. Teva Introduction and Business Overview
    Table 84. Teva Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Teva Cinnarizine Product Offerings
    Table 86. Teva Recent Development
    Table 87. Sopharma Company Information
    Table 88. Sopharma Introduction and Business Overview
    Table 89. Sopharma Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Sopharma Cinnarizine Product Offerings
    Table 91. Sopharma Recent Development
    Table 92. Aurobindo Pharma Company Information
    Table 93. Aurobindo Pharma Introduction and Business Overview
    Table 94. Aurobindo Pharma Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Aurobindo Pharma Cinnarizine Product Offerings
    Table 96. Aurobindo Pharma Recent Development
    Table 97. Novartis Company Information
    Table 98. Novartis Introduction and Business Overview
    Table 99. Novartis Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Novartis Cinnarizine Product Offerings
    Table 101. Novartis Recent Development
    Table 102. Mylan Company Information
    Table 103. Mylan Introduction and Business Overview
    Table 104. Mylan Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Mylan Cinnarizine Product Offerings
    Table 106. Mylan Recent Development
    Table 107. Eurogenerics Company Information
    Table 108. Eurogenerics Introduction and Business Overview
    Table 109. Eurogenerics Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Eurogenerics Cinnarizine Product Offerings
    Table 111. Eurogenerics Recent Development
    Table 112. Nidda Healthcare Company Information
    Table 113. Nidda Healthcare Introduction and Business Overview
    Table 114. Nidda Healthcare Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Nidda Healthcare Cinnarizine Product Offerings
    Table 116. Nidda Healthcare Recent Development
    Table 117. Apotex Company Information
    Table 118. Apotex Introduction and Business Overview
    Table 119. Apotex Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Apotex Cinnarizine Product Offerings
    Table 121. Apotex Recent Development
    Table 122. Leti Pharma Company Information
    Table 123. Leti Pharma Introduction and Business Overview
    Table 124. Leti Pharma Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Leti Pharma Cinnarizine Product Offerings
    Table 126. Leti Pharma Recent Development
    Table 127. Allena Pharmaceuticals Company Information
    Table 128. Allena Pharmaceuticals Introduction and Business Overview
    Table 129. Allena Pharmaceuticals Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Allena Pharmaceuticals Cinnarizine Product Offerings
    Table 131. Allena Pharmaceuticals Recent Development
    Table 132. Inga Laboratories Company Information
    Table 133. Inga Laboratories Introduction and Business Overview
    Table 134. Inga Laboratories Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Inga Laboratories Cinnarizine Product Offerings
    Table 136. Inga Laboratories Recent Development
    Table 137. March Pharma Company Information
    Table 138. March Pharma Introduction and Business Overview
    Table 139. March Pharma Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. March Pharma Cinnarizine Product Offerings
    Table 141. March Pharma Recent Development
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Cinnarizine Downstream Customers
    Table 145. Cinnarizine Distributors List
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cinnarizine Product Picture
    Figure 2. Global Cinnarizine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Cinnarizine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Cinnarizine Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Cinnarizine Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Cinnarizine Report Years Considered
    Figure 7. Global Cinnarizine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Cinnarizine Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cinnarizine Revenue in 2023
    Figure 10. Cinnarizine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Hospital Picture
    Figure 12. Drug Store Picture
    Figure 13. On-line Picture
    Figure 14. Global Cinnarizine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Cinnarizine Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Cinnarizine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Cinnarizine Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Cinnarizine Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Antiemetic Agent
    Figure 20. Product Picture of Histamine H₁-Receptor Antagonist
    Figure 21. Product Picture of Antivertigo Agent
    Figure 22. Global Cinnarizine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Cinnarizine Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Cinnarizine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Cinnarizine Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Cinnarizine Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Cinnarizine Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Cinnarizine Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Cinnarizine Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Cinnarizine Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Cinnarizine Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Cinnarizine Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Cinnarizine Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Cinnarizine Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Cinnarizine Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Cinnarizine Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Cinnarizine Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Cinnarizine Sales Volume (%), (2019-2030)
    Figure 39. United States Cinnarizine Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Cinnarizine Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Cinnarizine Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Cinnarizine Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Cinnarizine Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Cinnarizine Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Cinnarizine Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Cinnarizine Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Cinnarizine Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Cinnarizine Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Cinnarizine Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Cinnarizine Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Cinnarizine Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Cinnarizine Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Cinnarizine Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Cinnarizine Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Cinnarizine Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Cinnarizine Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Cinnarizine Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Cinnarizine Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Cinnarizine Sales Value by Application (%), 2023 VS 2030
    Figure 60. Cinnarizine Industrial Chain
    Figure 61. Cinnarizine Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global RANKL Inhibitors Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35Z18485
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Morphine Test Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-28M18423
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Moclobemide Film-coated Tablets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-9U15196
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global ADHD Medications Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-14K1494
Thu Dec 12 00:00:00 UTC 2024

Add to Cart